Today's health news spans infectious disease screening gaps, cardiovascular risk factors, treatment access disparities, and emerging therapies across multiple conditions including stroke, myasthenia gravis, and long COVID.

Less than half of infants perinatally exposed to hepatitis C are being tested, and few eligible young children receive antiviral medications despite the infection being treatable, indicating significant gaps in pediatric screening and treatment protocols.

Elevated lipoprotein(a) levels have been identified as a key marker of residual cardiovascular risk, particularly concerning for patients who already have existing cardiovascular disease, suggesting need for better risk stratification strategies.

The Stroke Association reports that thousands of patients annually are denied access to thrombectomy, a life-altering stroke treatment, due to patchy availability of 24/7 services, highlighting critical disparities in acute stroke care access.

NICE has recommended rozanolixizumab as the first NHS-funded treatment for adults with uncontrolled generalized myasthenia gravis, marking a significant advance in treatment options for this neuromuscular disorder.

An oral deuterated pentoxifylline analog shows promise in phase 2 trials for necrobiosis lipoidica, a rare skin disease, demonstrating favorable safety profiles and improved clinical outcomes for patients with this condition.

As GLP-1 medication use increases and bariatric surgery rates decline, surgical practices are adapting their business models to offer comprehensive obesity care that integrates both medical and surgical treatment approaches.

Machine learning models demonstrate improved performance over conventional regression methods in predicting which children hospitalized for asthma will face readmission within 180 days, potentially enabling better preventive interventions.

Researchers have identified biologic abnormalities in long COVID patients, providing evidence that challenges the prevailing view that symptoms are primarily psychosomatic and supporting the need for biological investigation of the condition.